Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hologic, Inc. stock logo
HOLX
Hologic
$64.74
-0.9%
$60.71
$51.90
$84.67
$14.44B0.552.37 million shs1.23 million shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$24.17
-1.4%
$23.71
$20.61
$31.57
$23.27B0.76899,654 shs871,452 shs
Insulet Corporation stock logo
PODD
Insulet
$301.14
-0.2%
$303.07
$173.00
$329.33
$21.19B1.35719,086 shs527,286 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$221.75
+0.2%
$215.83
$187.43
$352.33
$15.97B1.09735,377 shs370,766 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hologic, Inc. stock logo
HOLX
Hologic
0.00%-0.42%+3.46%+6.37%-11.90%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.00%+0.12%+5.13%+9.45%-7.09%
Insulet Corporation stock logo
PODD
Insulet
0.00%-3.82%-5.66%+22.78%+53.08%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.00%+1.23%+4.80%+9.23%-31.01%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Hologic, Inc. stock logo
HOLX
Hologic
4.8239 of 5 stars
3.24.00.04.32.93.31.9
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
3.6907 of 5 stars
0.05.01.70.02.70.03.1
Insulet Corporation stock logo
PODD
Insulet
4.2088 of 5 stars
2.43.00.04.92.70.81.9
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.7625 of 5 stars
3.44.01.73.22.41.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hologic, Inc. stock logo
HOLX
Hologic
2.41
Hold$77.4219.59% Upside
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
3.00
BuyN/AN/A
Insulet Corporation stock logo
PODD
Insulet
2.83
Moderate Buy$321.006.60% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.89
Moderate Buy$320.0044.31% Upside

Current Analyst Ratings Breakdown

Latest HOLX, PHG, WST, and PODD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$245.00
6/16/2025
Insulet Corporation stock logo
PODD
Insulet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$365.00
5/30/2025
Insulet Corporation stock logo
PODD
Insulet
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$380.00
5/27/2025
Hologic, Inc. stock logo
HOLX
Hologic
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
5/27/2025
Insulet Corporation stock logo
PODD
Insulet
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$328.00 ➝ $360.00
5/22/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/22/2025
Insulet Corporation stock logo
PODD
Insulet
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00 ➝ $380.00
5/16/2025
Insulet Corporation stock logo
PODD
Insulet
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/13/2025
Hologic, Inc. stock logo
HOLX
Hologic
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$77.00 ➝ $70.00
5/13/2025
Insulet Corporation stock logo
PODD
Insulet
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$350.00
5/9/2025
Insulet Corporation stock logo
PODD
Insulet
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$312.00 ➝ $324.00
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hologic, Inc. stock logo
HOLX
Hologic
$4.03B3.58$5.50 per share11.78$22.09 per share2.93
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$19.50B1.19$3.10 per share7.80$13.86 per share1.74
Insulet Corporation stock logo
PODD
Insulet
$2.07B10.23$4.44 per share67.86$17.27 per share17.44
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B5.51$8.99 per share24.67$37.04 per share5.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$2.3727.3114.012.3713.83%19.71%10.87%7/30/2025 (Estimated)
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
-$758.55M$0.4356.2112.520.682.11%10.97%4.57%7/29/2025 (Estimated)
Insulet Corporation stock logo
PODD
Insulet
$418.30M$5.5654.1660.592.6918.29%22.25%8.29%8/6/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.3734.8128.215.4716.13%18.23%13.51%7/24/2025 (Estimated)

Latest HOLX, PHG, WST, and PODD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2025Q3 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.05N/AN/AN/A$1.01 billionN/A
7/29/2025Q2 2025
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.2907N/AN/AN/A$4.35 billionN/A
7/24/2025Q2 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.51N/AN/AN/A$725.11 millionN/A
5/8/2025Q1 2025
Insulet Corporation stock logo
PODD
Insulet
$0.81$1.02+$0.21$0.50$543.20 million$569.00 million
5/6/2025Q1 2025
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.14$0.27+$0.13$0.09$4.10 billion$4.31 billion
5/1/2025Q2 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01-$0.08$1.00 billion$1.01 billion
4/24/2025Q1 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.22$1.45+$0.23$1.23$685.24 million$698.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.823.39%N/A190.70%N/A
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.38%N/A13.19%N/A

Latest HOLX, PHG, WST, and PODD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.210.39%7/30/20257/30/20258/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hologic, Inc. stock logo
HOLX
Hologic
0.54
3.24
2.52
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.60
1.28
0.79
Insulet Corporation stock logo
PODD
Insulet
1.21
4.47
3.63
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.08
2.77
2.03

Institutional Ownership

CompanyInstitutional Ownership
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
13.67%
Insulet Corporation stock logo
PODD
Insulet
N/A
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
N/A
Insulet Corporation stock logo
PODD
Insulet
0.39%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hologic, Inc. stock logo
HOLX
Hologic
7,063222.85 million218.66 millionOptionable
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
66,678962.92 millionN/AOptionable
Insulet Corporation stock logo
PODD
Insulet
3,90070.38 million70.10 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60071.85 million71.46 millionOptionable

Recent News About These Companies

Investors in West Pharmaceutical Services, Inc. ...
West Pharmaceutical Services (WST) Fell on Lowered Guidance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hologic stock logo

Hologic NASDAQ:HOLX

$64.74 -0.57 (-0.87%)
As of 07/3/2025 03:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Koninklijke Philips stock logo

Koninklijke Philips NYSE:PHG

$24.17 -0.35 (-1.43%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$24.18 +0.00 (+0.02%)
As of 07/3/2025 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Insulet stock logo

Insulet NASDAQ:PODD

$301.14 -0.49 (-0.16%)
Closing price 07/3/2025 01:23 PM Eastern
Extended Trading
$301.14 0.00 (0.00%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$221.75 +0.53 (+0.24%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$221.74 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.